B7-1 (CD80) Rabbit Polyclonal Antibody

CAT#: TA355032

Rabbit Polyclonal Anti-CD80 Antibody



Need it in bulk or conjugated?
Get a free quote

CNY 5808.00


货期*
5周

规格
    • 100 ug

Cited in 3 publications.

Product images

推荐一起购买 (2)
beta Actin Mouse Monoclonal Antibody, Clone OTI1, Loading Control
    • 30 ul

CNY 300.00
CNY 1430.00


Recombinant protein of human CD80 molecule (CD80), 100 µg
    • 100 ug

CNY 9998.00

Specifications

Product Data
Applications ELISA, IF, IHC, WB
Recommend Dilution WB: 1-4 µg/mL
IHC-P/IF: 5-20 µg/mL.

Antibody validated: Western Blot in human, mouse and rat samples
Immunofluorescence in the human, mouse and rat samples. All other applications and species not yet tested.
Reactivity Human, Mouse, Human, Mouse, Rat
Host Rabbit
Clonality Polyclonal
Immunogen Anti-CD80 antibody (8679) was raised against a peptide corresponding to 17 amino acid synthetic peptide near the amino terminus of human CD80.

The immunogen is located within amino acids 60-110 of CD80.
Isotype IgG
Formulation CD80 Antibody is supplied in PBS containing 0.02% sodium azide.
Concentration 1 mg/mL
Purification CD80 Antibody is affinity chromatography purified via peptide column.
Conjugation Unconjugated
Storage Condition CD80 antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Predicted Protein Size Predicted: 60 kD

Observed: 60 kD
Gene Name CD80 molecule
Background CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2).
Synonyms B7; BB1; CD28LG; CD28LG1; LAB7
Note Optimal dilutions for each application to be determined by the researcher.
Reference Data
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Citations (3)

Customer Reviews 
Loading...